Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT01966003 · COMPLETED

Trial details

NCT number: NCT01966003
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic

Start date: 2013-11-11
Primary completion: 2015-07-23
Enrollment: 642

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.